用经过亲水处理的塑料板诊断疟疾
|
By Liu Jianrong, news writer 刘建荣 新闻记者 Posted on 12 Nov 2017 |
|
图片：经过吉姆萨染色和亲水处理的COC板的典型图像；箭头表示感染疟原虫的细胞（图片蒙国家先进工业科技研究所惠赐）。
疟疾是由疟原虫引起的一种红细胞(RBC)感染，红细胞感染率对于研究和诊断疟疾至关重要，可通过显微镜检查玻片上的吉姆萨染色薄血液涂片确定红细胞感染率。
然而，血液涂片上只有一小块适合用以确定感染率的单层红细胞，这是吉姆萨显微镜检检测寄生虫感染的准确率低的主要原因之一。此外，因为吉姆萨显微镜检条件严苛且耗时，所以亟需自动测量感染率。
日本东京国家先进工业科技研究所(AIST)的科学家培养了一种恶性疟原虫，以自动计数寄生虫感染；用可透过细胞的绿荧光核酸染料对感染寄生虫的红细胞染色。用德国韦茨拉尔市徕卡微系统公司的DM1L倒置荧光显微镜获得经染色的感染寄生虫红细胞的明场图像和荧光图像。
研究人员开发了一种方法，用显微镜检查几乎铺满经过亲水处理的环烯烃共聚物(COC)板整个表面的单层吉姆萨染色细胞。因为能在经过亲水处理的板上执行多种多样的吉姆萨显微镜检，所以该方法也许能更可靠地诊断低寄生虫血症患者体内的疟疾。还能用荧光核染料对红细胞和寄生虫染色，并用软件工具自动计数，无需吉姆萨染色。结果，检查疟疾的医务人员能轻松、快速、准确地计算感染率，即使是低寄生虫血症。
该研究的论文发表于2017年8月8日的《疟疾杂志》(Malaria Journal)。作者总结说，这些方法的运行成本极低，不涉及复杂技术，而且使用亲水的COC板也许有助于更好、更准确地诊断疟疾。
Related Links:
国家先进工业科技研究所
徕卡微系统公司
然而，血液涂片上只有一小块适合用以确定感染率的单层红细胞，这是吉姆萨显微镜检检测寄生虫感染的准确率低的主要原因之一。此外，因为吉姆萨显微镜检条件严苛且耗时，所以亟需自动测量感染率。
日本东京国家先进工业科技研究所(AIST)的科学家培养了一种恶性疟原虫，以自动计数寄生虫感染；用可透过细胞的绿荧光核酸染料对感染寄生虫的红细胞染色。用德国韦茨拉尔市徕卡微系统公司的DM1L倒置荧光显微镜获得经染色的感染寄生虫红细胞的明场图像和荧光图像。
研究人员开发了一种方法，用显微镜检查几乎铺满经过亲水处理的环烯烃共聚物(COC)板整个表面的单层吉姆萨染色细胞。因为能在经过亲水处理的板上执行多种多样的吉姆萨显微镜检，所以该方法也许能更可靠地诊断低寄生虫血症患者体内的疟疾。还能用荧光核染料对红细胞和寄生虫染色，并用软件工具自动计数，无需吉姆萨染色。结果，检查疟疾的医务人员能轻松、快速、准确地计算感染率，即使是低寄生虫血症。
该研究的论文发表于2017年8月8日的《疟疾杂志》(Malaria Journal)。作者总结说，这些方法的运行成本极低，不涉及复杂技术，而且使用亲水的COC板也许有助于更好、更准确地诊断疟疾。
Related Links:
国家先进工业科技研究所
徕卡微系统公司
Gold Member
Hybrid Pipette
SWITCH
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Latest 实验室技术 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more